205 related articles for article (PubMed ID: 8098243)
1. Comparison of antihypertensive and beta 1-adrenoceptor antagonist effect of nebivolol and atenolol in essential hypertension.
Simon G; Johnson ML
Clin Exp Hypertens; 1993 May; 15(3):501-9. PubMed ID: 8098243
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes.
Fogari R; Zoppi A; Lazzari P; Mugellini A; Lusardi P; Preti P; Van Nueten L; Vertommen C
J Hum Hypertens; 1997 Nov; 11(11):753-7. PubMed ID: 9416986
[TBL] [Abstract][Full Text] [Related]
3. Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension.
Pesant Y; Marc-Aurèle J; Bielmann P; Alaupovic P; Cartier P; Bichet D; Thibault G; Lupien PJ
Am J Ther; 1999 May; 6(3):137-47. PubMed ID: 10423656
[TBL] [Abstract][Full Text] [Related]
4. Nebivolol vs atenolol and placebo in essential hypertension: a double-blind randomised trial.
Van Nueten L; Taylor FR; Robertson JI
J Hum Hypertens; 1998 Feb; 12(2):135-40. PubMed ID: 9504355
[TBL] [Abstract][Full Text] [Related]
5. Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients.
Poirier L; Cléroux J; Nadeau A; Lacourcière Y
J Hypertens; 2001 Aug; 19(8):1429-35. PubMed ID: 11518851
[TBL] [Abstract][Full Text] [Related]
6. Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life.
Van Bortel LM; Breed JG; Joosten J; Kragten JA; Lustermans FA; Mooij JM
J Cardiovasc Pharmacol; 1993 Jun; 21(6):856-62. PubMed ID: 7687708
[TBL] [Abstract][Full Text] [Related]
7. Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.
Tzemos N; Lim PO; MacDonald TM
Circulation; 2001 Jul; 104(5):511-4. PubMed ID: 11479245
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the efficacy and tolerability of nebivolol versus lisinopril in the treatment of essential arterial hypertension: a randomized, multicentre, double-blind study.
Rosei EA; Rizzoni D; Comini S; Boari G;
Blood Press Suppl; 2003 May; 1():30-5. PubMed ID: 12800985
[TBL] [Abstract][Full Text] [Related]
9. Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction.
Rousseau MF; Chapelle F; Van Eyll C; Stoleru L; Hager D; Van Nueten L; Pouleur H
J Card Fail; 1996 Mar; 2(1):15-23. PubMed ID: 8798100
[TBL] [Abstract][Full Text] [Related]
10. Effects of nebivolol and atenolol on central aortic pressure in hypertensive patients: a multicenter, randomized, double-blind study.
Redón J; Pascual-Izuel JM; Rodilla E; Vicente A; Oliván J; Bonet J; Torguet JP; Calaforra O; Almirall J
Blood Press; 2014 Jun; 23(3):181-8. PubMed ID: 24059690
[TBL] [Abstract][Full Text] [Related]
11. Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol.
Nodari S; Metra M; Dei Cas L
Eur J Heart Fail; 2003 Oct; 5(5):621-7. PubMed ID: 14607201
[TBL] [Abstract][Full Text] [Related]
12. Nebivolol in the management of essential hypertension: a review.
McNeely W; Goa KL
Drugs; 1999 Apr; 57(4):633-51. PubMed ID: 10235696
[TBL] [Abstract][Full Text] [Related]
13. Determination of the anti-ischemic activity of nebivolol in comparison with atenolol.
Ruf G; Trenk D; Jähnchen E; Roskamm H
Int J Cardiol; 1994 Mar; 43(3):279-85. PubMed ID: 7910155
[TBL] [Abstract][Full Text] [Related]
14. The application of nebivolol in essential hypertension: a double-blind, randomized, placebo-controlled study.
Chan TY; Woo KS; Nicholls MG
Int J Cardiol; 1992 Jun; 35(3):387-95. PubMed ID: 1351888
[TBL] [Abstract][Full Text] [Related]
15. Nebivolol versus nifedipine in the treatment of essential hypertension: a double-blind, randomized, comparative trial.
Van Nueten L; Lacourcière Y; Vyssoulis G; Korlipara K; Marcadet DM; Dupont AG; Robertson JI
Am J Ther; 1998 Jul; 5(4):237-43. PubMed ID: 10099065
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men.
Brixius K; Middeke M; Lichtenthal A; Jahn E; Schwinger RH
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):327-31. PubMed ID: 17324145
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.
Grassi G; Trevano FQ; Facchini A; Toutouzas T; Chanu B; Mancia G
Blood Press Suppl; 2003 Dec; 2():35-40. PubMed ID: 14761075
[TBL] [Abstract][Full Text] [Related]
18. Effects of nebivolol and atenolol on small arteries and microcirculatory endothelium-dependent dilation in hypertensive patients undergoing isometric stress.
Arosio E; De Marchi S; Prior M; Zannoni M; Lechi A
J Hypertens; 2002 Sep; 20(9):1793-7. PubMed ID: 12195121
[TBL] [Abstract][Full Text] [Related]
19. Exercise tolerance with nebivolol and atenolol.
Van Bortel LM; van Baak MA
Cardiovasc Drugs Ther; 1992 Jun; 6(3):239-47. PubMed ID: 1353367
[TBL] [Abstract][Full Text] [Related]
20. Comparative assessment of antihypertensive efficacy of DL-nebivolol and D-nebivolol in patients with confirmed mild to moderate hypertension.
Lacourcière Y; Poirier L; Lefebvre J; Archambault F; Cléroux J
J Cardiovasc Pharmacol; 1995 Apr; 25(4):619-24. PubMed ID: 7596131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
